Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.
about
Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cellsInhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to PraziquantelRole of the Drug Transporter ABCC3 in Breast Cancer ChemoresistanceTargeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment responseA selective ATP-binding cassette subfamily G member 2 efflux inhibitor revealed via high-throughput flow cytometry.Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer modelABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.Anticancer Activity of Saponins from Allium chinense against the B16 Melanoma and 4T1 Breast Carcinoma Cell.Autophagy is associated with chemoresistance in neuroblastoma.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.p53 family: Therapeutic targets in neuroblastoma.Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.Investigational ABC transporter inhibitors.Current progress for the use of miRNAs in glioblastoma treatment.Neuroblastoma models for insights into tumorigenesis and new therapies.Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication.Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner.ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma.Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme.Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis.An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced ApoptosisMultilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs
P2860
Q24614785-69B4018D-5752-49BE-BE3B-9A7A5D153FFBQ28543846-0E0EC82E-83BF-42DB-851D-B43343A148E6Q28552011-B28A793B-39F3-411F-9333-A9037DC75F57Q33763765-604564F3-802D-4519-A463-1F6D2D02B273Q34051930-514020C8-8A93-4C63-9A4A-7A0A9D79C099Q34393952-1CB90B01-87DF-4447-B083-B67C086C5E3DQ34755674-A3FC8849-B948-45BE-A250-505887465D61Q35166695-8364F65A-3ECB-437C-965E-FC9B416417AFQ35585361-13638EC8-DE1F-4167-8F60-997A9B3B04A8Q35749385-92A606A6-9D38-4EDD-8CF8-06D550ABEAB7Q36193465-D087294A-7124-4A9C-819F-B65D6DCF365FQ37576360-982C9ECD-EC5E-4D3F-B15C-08CFEDD25492Q37693722-C61E80B9-8CD5-44BD-BB83-AEE9CE4BAC17Q37706888-02ADF12A-125A-4BA3-A607-7B718AD1A70AQ37707387-27440CBE-326F-44B2-A14E-0306C28A4C20Q37940719-3BD48A81-11F5-4B13-90C4-D0EF498C3870Q38001734-FA70D724-45B0-4AEA-AD82-FB2E40704C98Q38102611-18A9B4DA-AA9A-4C1F-A2BA-863D1EA377F8Q38262762-C496D786-26C3-4C0A-B38D-FBF9FE0B1451Q39018864-36E445C0-B913-4F76-8CDA-4CECF5CBF706Q39032170-472051E0-BA19-43A9-BD3A-8F12D2ACF638Q39316019-F2FC4FB3-9C2F-47B3-B73F-0650EFC6A27BQ39498028-7E3A3ECA-9C25-416F-BCB5-4079AEC8D40CQ42154258-5D40965A-CFAB-4E2E-8540-70AE39911BFAQ42282862-CAD4072C-5191-4981-A23E-27E704408D50Q42846693-011A89E1-17C9-415D-8F60-D2A863A50C32Q48714552-4A70E7D3-D80D-4099-9578-0650FAC0EA9BQ52719561-2A1AB67A-2C60-46BD-8778-FEB38F82CB7BQ58122091-06EFCDD3-E871-4B49-A927-AA1313681CFBQ58701299-3DE73E09-477B-4E5F-AAE4-A33A7FFF5F4A
P2860
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Small-molecule multidrug resis ...... mouse models of neuroblastoma.
@ast
Small-molecule multidrug resis ...... mouse models of neuroblastoma.
@en
type
label
Small-molecule multidrug resis ...... mouse models of neuroblastoma.
@ast
Small-molecule multidrug resis ...... mouse models of neuroblastoma.
@en
prefLabel
Small-molecule multidrug resis ...... mouse models of neuroblastoma.
@ast
Small-molecule multidrug resis ...... mouse models of neuroblastoma.
@en
P2093
P2860
P1433
P1476
Small-molecule multidrug resis ...... mouse models of neuroblastoma.
@en
P2093
Alan C Sartorelli
Anatoly Prokvolit
Andrei Purmal
Catherine A Burkhart
Chengyuan Xue
Claudia Flemming
Fujiko Watt
Glenn M Marshall
Janice Smith
Jayne Murray
P2860
P304
P356
10.1158/0008-5472.CAN-09-1075
P407
P577
2009-08-04T00:00:00Z